Sodium hydride → 3-(2-Fluorophenyl)-6-(2-methyl-2H-1,2,4-triazol-3-ylmethoxy)-7-(thien-2-yl)-1,2,4-triazolo[4,3-b]pyridazine
反応式
[CH3:1][N:2]1[C:6]([CH2:7][OH:8])=[N:5][CH:4]=[N:3]1.[H-].[Na+].Cl[C:12]1[C:13]([C:28]2[S:29][CH:30]=[CH:31][CH:32]=2)=[CH:14][C:15]2[N:16]([C:18]([C:21]3[CH:26]=[CH:25][CH:24]=[CH:23][C:22]=3[F:27])=[N:19][N:20]=2)[N:17]=1>CN(C=O)C.O>[F:27][C:22]1[CH:23]=[CH:24][CH:25]=[CH:26][C:21]=1[C:18]1[N:16]2[N:17]=[C:12]([O:8][CH2:7][C:6]3[N:2]([CH3:1])[N:3]=[CH:4][N:5]=3)[C:13]([C:28]3[S:29][CH:30]=[CH:31][CH:32]=3)=[CH:14][C:15]2=[N:20][N:19]=1参加物
反応物 3
生成物 1
試薬・触媒・溶媒 2
実験手順
To a solution of (2-methyl-2H-1,2,4-triazol-3-yl)methanol (0.11 g, 1.0 mmol) (prepared using the conditions described in EP-A-421210) in DMF (5 ml) was added sodium hydride (0.04 g of a 60% dispersion in oil, 1 mol eq) and the reaction mixture was stirred at room temperature for 30 min. After this time 6-chloro-3-(2-fluorophenyl)-7-(thien-2-yl)-1,2,4-triazolo[4,3-b]pyridazine (0.19 g, 0.57 mmol) was added and the reaction mixture was stirred at room temperature for 18 h. The reaction mixture was diluted with water (70 ml) and the precipitate was collected. The solid was purified by boiling in ethyl acetate and collecting the title compound as a yellow solid (0.01 g, 12%). 1H NMR (250 MHz, d6-DMSO) δ 3.83 (3H, s), 5.64 (2H, s), 7.24 (1H, dd, J 4 and 4 Hz), 7.44-7.55 (2H, m), 7.66-7.71 (1H, m), 7.82 (1H, d, J=5 Hz), 7.96-8.01 (3H, m), 8.23 (1H, s). MS (ES+) m/e 408 [MH]+. Anal. Found C, 53.81; H, 3.62; N, 23.42%. C19H14FN7OS.0.9(H2O) requires C, 53.87; H, 3.76; N, 23.14% m.p. 189-190° C.
後処理
- stirringthe reaction mixture was stirred at room temperature for 18 h
- customthe precipitate was collected
- customThe solid was purified
- customcollecting the title compound as a yellow solid (0.01 g, 12%)
出典と根拠
- ORDレコード
- ord-ab9f4f2c95774b7c907423494f2f75f2
- 出典データセット
- uspto-grants-2004_12
- 特許番号
- US06828322B2
反応ノート
読み込み中…